Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04744025 · ClinicalTrials.gov registry record · NA

Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates

A NA study of Infertility and Recurrent Pregnancy Loss, sponsored by Lawrence Engmann.

Active
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT04744025 is a NA study of Infertility and Recurrent Pregnancy Loss that is active but no longer recruiting, run by Lawrence Engmann. The registered enrollment target is 150 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04744025, a NA study of Infertility and Recurrent Pregnancy Loss, is active but no longer recruiting, sponsored by Lawrence Engmann.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This research is being done to determine if using a microfluidics chamber, a device used to process sperm, will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothesize that this device is effective at improving rates of normal chromosomes among embryos.

Interventions

  • DEVICE Microfluidics chamber
  • OTHER Density Gradient Centrifugation

Study Locations (1)

Connecticut

  • The Center for Advanced Reproductive Services - Farmington

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2021-01-13
Est. Completion 2022-12-31
Phase NA

Sponsor

Lawrence Engmann

1 total trials

What the Registry Record Tells You About NCT04744025

The ClinicalTrials.gov registry entry for NCT04744025 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The listed sponsor is Lawrence Engmann, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Microfluidics chamber is the first listed.

NCT04744025 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04744025 about?

NCT04744025 is a clinical study titled "Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates". This research is being done to determine if using a microfluidics chamber, a device used to process sperm, will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) treatment. The investigators hypothes...

What is the current status of trial NCT04744025?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-01-13. Estimated completion is 2022-12-31.

What conditions does trial NCT04744025 study?

This clinical trial studies the following conditions: Infertility, Recurrent Pregnancy Loss.

What interventions are being tested in trial NCT04744025?

The interventions under investigation include: Microfluidics chamber (DEVICE), Density Gradient Centrifugation (OTHER).

Who is sponsoring clinical trial NCT04744025?

This trial is sponsored by Lawrence Engmann, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04744025 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.